Airz-F Capsule

Description

Airz-F Capsule is a dual bronchodilator inhalation therapy used for the long-term management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It contains Formoterol, a long-acting beta-agonist (LABA) that relaxes the airway muscles and provides sustained relief from breathlessness, and Glycopyrrolate, a long-acting muscarinic antagonist (LAMA) that prevents airway narrowing. This combination ensures improved airflow, better symptom control, and enhanced lung performance in COPD patients.

Uses

• Maintenance treatment of COPD symptoms

• Relieves shortness of breath, wheezing, and chest tightness

• Improves exercise tolerance and daily activity performance

• Reduces the frequency of COPD exacerbations and flare-ups

Dosage

• Usually prescribed as 1 capsule inhaled twice daily, or as directed by the physician.

• Must be taken consistently at the same time every day for maximum benefit.

• Not intended for sudden asthma or COPD attacks (a rescue inhaler is required in emergencies).

Possible Side Effects

• Dry mouth or throat irritation

• Mild cough or hoarseness

• Headache or dizziness

• Constipation or urinary difficulty (in rare cases)

• Tremors, palpitations, or muscle cramps (uncommon)

About the Company

Glenmark Pharmaceuticals Ltd is a globally recognized pharmaceutical company known for its strong portfolio in respiratory care. With its innovative inhalation therapies, Glenmark has improved access to effective and affordable treatments for asthma and COPD worldwide.

Good Things About Airz-F Capsule

• Provides dual bronchodilation (LABA + LAMA) for enhanced airway opening

• Offers long-lasting symptom relief with twice-daily use

• Improves lung function and reduces dependence on rescue medications

• Enhances patient comfort and daily activity levels

• Manufactured by Glenmark, a trusted leader in respiratory therapies